We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ORGN:NASDAQOrigin Materials, Inc. Analysis

Data as of 2026-05-19 - not real-time

$1.53

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Origin Materials is trading well below its long‑term average, with the 20‑day SMA (≈$1.87) already under the 50‑day SMA (≈$2.47) and dramatically distant from the 200‑day SMA (≈$10.33), signaling a prolonged downtrend. The RSI sits at 38, indicating modest oversold pressure but not yet a clear reversal, while the MACD histogram turned marginally positive, offering only a faint bullish hint that has not overcome the overall bearish trend direction. Volatility is extreme at over 195% on a 30‑day basis and beta exceeds 1.6, exposing the stock to outsized market swings, compounded by a historic max drawdown of roughly 95%. Fundamental metrics are equally distressing: negative earnings, a trailing PE of zero, a P/B of 0.08 and a price‑to‑sales under 1, yet operating cash flow and free cash flow are deeply negative, and the balance sheet shows a debt‑to‑equity ratio near 26%. The latest material news confirms that the board has approved a technology sale and an orderly wind‑down, positioning liquidation as the preferred route to preserve any residual shareholder value. With market cap under $9 million, thin liquidity and a support level just above $1.22, any upside is tightly constrained.
Given these dynamics, the stock’s price action is dominated by technical weakness, severe financial strain, and a definitive strategic pivot toward dissolution. The convergence of a bearish technical setup, extreme price volatility, and a corporate plan to liquidate assets suggests that the remaining upside is limited to the modest premium that a liquidation may deliver over current levels. Investors should therefore treat ORGN as a high‑risk, value‑oriented play with minimal upside potential and consider exiting positions promptly.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 9/10

Key Factors

  • Board‑approved liquidation and technology sale
  • Bearish technical indicators (price below SMA20/50, bearish trend)
  • Extreme volatility and high beta

Medium Term

1–3 years
Cautious
Model confidence: 8/10

Key Factors

  • Continued negative cash flows and operating losses
  • Low market capitalization and thin trading volume
  • Potential further price erosion as wind‑down proceeds are realized

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Fundamental insolvency risk and high max drawdown
  • Absence of dividend or earnings recovery prospects
  • Structural sector challenges for small‑cap chemical firms

Key Metrics & Analysis

Financial Health

Revenue Growth-91.20%
P/E Ratio-4.4
ROE-119.58%
ROA-16.52%
Debt/Equity25.87
P/B Ratio0.1
Op. Cash Flow$-29221000
Free Cash Flow$-36314752

Technical Analysis

TrendBearish
RSI38.6
Support$1.22
Resistance$2.66
MA 20$1.87
MA 50$2.47
MA 200$10.33
MACDBullish
VolumeIncreasing
Fear & Greed Index89.25

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta1.65
Volatility195.27%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.